$XERS 8-K SEC Filings

Filed On	Filing
14 Oct 2026	8-K: Other Events On October 13, 2026, Xeris Biopharma Holdings, Inc. (the “Company”), through its wholly owned subsidiary, Xeris Pharmaceuticals, Inc., filed patent infringement lawsuits in the United States District Court for the District of New Jersey ...
09 Sep 2026	8-K: Regulation FD Disclosure Copyright © 2021-2026 Xeris Pharmaceuticals, Inc. All rights reserved. Today’s Agenda 2 1 Welcome & Introductions Allison Wey — SVP, Investor Relations 2 Becoming the Next Great Biopharmaceutical Company John Shannon – Chairman and Chief...
06 Aug 2026	8-K: Results of Operations and Financial Condition
17 Jul 2026	8-K: Unregistered Sales of Equity Securities; Other Events
30 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
11 Jun 2026	8-K: Unregistered Sales of Equity Securities; Other Events
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
21 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
02 Mar 2026	8-K: Results of Operations and Financial Condition
27 Feb 2026	8-K: Regulation FD Disclosure
08 Jan 2026	8-K: Results of Operations and Financial Condition
01 Dec 2025	8-K: Regulation FD Disclosure
06 Nov 2025	8-K: Results of Operations and Financial Condition
07 Aug 2025	8-K: Results of Operations and Financial Condition
04 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2025	8-K: Regulation FD Disclosure
08 May 2025	8-K: Results of Operations and Financial Condition
28 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
06 Mar 2025	8-K: Results of Operations and Financial Condition

Comments